Fate Therapeutics logo

Fate Therapeutics Funding & Investors

Fate Therapeutics, Inc. provides biotechnology services. The Company researches and develops therapies to repair and regenerate body tissues with the help of stem cells. Fate Therapeutics conducts business in the United States.

fatetherapeutics.com

Total Amount Raised: $1,240,928,256

Fate Therapeutics Funding Rounds

  • Post Ipo Equity

    $432,000,000

  • Post Ipo Equity

    $201,300,000

  • Post Ipo Equity

    $173,000,000

  • Post Ipo Equity

    $172,500,000

  • Grant

    $4,000,000

    Grant Investors

    California Institute for Regenerative Medicine
  • Post Ipo Equity

    $42,900,000

  • Post Ipo Equity

    $56,749,988

  • Post Ipo Equity

    $10,290,000

  • Post Ipo Equity

    $32,000,000

  • Post Ipo Equity

    $8,000,000

  • Post Ipo Debt

    $20,000,000

    Post Ipo Debt Investors

    Silicon Valley Bank
  • Series Unknown

    $9,200,000

  • Series B

    $35,988,360

    Series B Investors

    Polaris Partners
    Astellas Venture Management
    Venrock
    Arch Venture Partners
    OVP Venture Partners
  • Debt Financing

    $1,000,000

  • Series B

    $30,000,000

    Series B Investors

    Polaris Partners
    Astellas Venture Management
    Venrock
    Arch Venture Partners
    Sanofi Ventures
    OVP Venture Partners
  • Series A

    $12,000,000

    Series A Investors

    Polaris Partners
    Venrock
    Arch Venture Partners
    OVP Venture Partners
  • IPO

    Unknown

Funding info provided by Diffbot.